RESUMEN
A 33-year-old woman admitted to our hospital for further examination of severe non-productive cough lasting for about two months. Her symptom did not ameliorate by treatments including long acting ß2 agonists. She had a medical history of drug allergy to non-steroidal anti-inflammatory drugs. At the initial visit, she could not speak at all and communicated with us in writing. Chest auscultation revealed no wheezes, rhonchi and other crackles. Laboratory findings showed a mild eosinophilia with normal total and specific serum immunoglobulin E. The results of an electrocardiogram, a chest X-ray and a chest CT were unremarkable. A fractional exhaled nitric oxide value was within normal limit. Based on these observations, a diagnosis of atopic cough (AC) was suspected, and we started treatment with a histamine H1 receptor antagonist (H1-RA). She had become able to speak again in association with complete disappearance of cough by eight-weeks after treatment initiation, and her symptoms did not recur even after cessation of treatment. By the confirmation of remarkable clinical improvement in response to a H1-RA, a diagnosis of AC was made. To the best of our knowledge, this is the first report of an AC patient who presented severe cough with aphonia. J. Med. Invest. 70 : 281-284, February, 2023.
Asunto(s)
Tos , Antagonistas de los Receptores Histamínicos H1 , Adulto , Femenino , Humanos , Afonía/complicaciones , Afonía/tratamiento farmacológico , Tos/tratamiento farmacológico , Tos/etiología , Antagonistas de los Receptores Histamínicos H1/uso terapéuticoAsunto(s)
Afonía/inducido químicamente , Distonía/inducido químicamente , Eméticos/efectos adversos , Proclorperazina/efectos adversos , Adulto , Antieméticos/uso terapéutico , Afonía/tratamiento farmacológico , Difenhidramina/uso terapéutico , Distonía/tratamiento farmacológico , Femenino , HumanosRESUMEN
PURPOSE: Aprosody and amusia are disorders commonly associated with right hemisphere abnormalities. They are regarded as negative phenomena and usually seen after strokes. We report a case of a patient who had both expressive aprosody and amusia as a clinical manifestation of right temporooccipital seizures. METHODS: A 43-year-old woman had a 1-month history of monotonic speech and difficulty singing. Her examination revealed both expressive aprosody and amusia. Magnetic resonance imaging of the head was normal, but her EEG revealed several electrographic seizures of right temporooccipital origin. RESULTS: Treatment with phenytoin (PHT) almost immediately caused her speech and singing to return to baseline. A repeated EEG was normal CONCLUSIONS: Seizures of right temporooccipital origin can manifest with expressive aprosody and amusia.
Asunto(s)
Afonía/diagnóstico , Electroencefalografía/estadística & datos numéricos , Lateralidad Funcional/fisiología , Música , Lóbulo Occipital/fisiopatología , Convulsiones/diagnóstico , Trastornos del Habla/diagnóstico , Lóbulo Temporal/fisiopatología , Adulto , Anticonvulsivantes/uso terapéutico , Afonía/tratamiento farmacológico , Afonía/fisiopatología , Femenino , Humanos , Fenitoína/uso terapéutico , Convulsiones/tratamiento farmacológico , Convulsiones/fisiopatología , Trastornos del Habla/tratamiento farmacológico , Trastornos del Habla/fisiopatología , Resultado del TratamientoRESUMEN
The paper reviews data on effective use of reflex therapy in laryngeal dysfunction: hypo- and hypertonicity dysphonia, spastic dysphonia, functional aphonia. Besides classical methods of acupuncture, effective were, especially in functional aphonia, novocaine blockades of laryngeal tender zones.
Asunto(s)
Reflejoterapia , Trastornos de la Voz/terapia , Adulto , Anestésicos Locales/uso terapéutico , Afonía/tratamiento farmacológico , Afonía/terapia , Femenino , Humanos , Masculino , Procaína/uso terapéutico , Trastornos de la Voz/tratamiento farmacológicoAsunto(s)
Afonía/patología , Hipofaringe/patología , Antiácidos/uso terapéutico , Afonía/tratamiento farmacológico , Afonía/fisiopatología , Femenino , Hernia Hiatal , Humanos , Hipofaringe/fisiopatología , Masculino , Tonsila Palatina/patología , Pliegues Vocales/patología , Pliegues Vocales/fisiopatologíaRESUMEN
The increasing diversity of purpose-built, synthetic and biogenetically engineered pharmaceuticals has led to a revival of interest in the pharmacological possibilities for the treatment of voice disorders. Where dysphonias arise as a part of a pathophysiological process, the pharmacological treatment of either the pathology or its associated symptoms may improve dysphonic voicing patterns. The treatment of symptoms such as cough and vocal fatigue are discussed together with treatment of allergic and other causes of inflammation or stiffening of the vocal tract. The pharmacological logical treatment of dysphonia due to defective neuromuscular control in dyskinetic and dystonic conditions is also discussed. Dysphonic voicing patterns are commonly multifactorial, and the author wishes to highlight problems encountered when attempting to adjust the performance of the vocal tract: imprecise targeting of the pathophysiological problems either by the physician or by the drug employed, and the systemic and attendant side-effects of drugs which may be thought to be appropriate.